Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzannah M Schmidt

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Diagnostic Microbiology and Infectious Disease|December 3, 2017
Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococciKatharina Neudorfer, Suzannah M Schmidt-Malan, Robin Patel
Journal of Experimental and Applied Animal Sciences|August 13, 2019
A novel rat model of foreign body osteomyelitis for evaluation of antimicrobial efficacyCassandra L Brinkman, Suzannah M Schmidt-Malan, Melissa J Karau, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2016
Rifampin-Based Combination Therapy Is Active in Foreign-Body Osteomyelitis after Prior Rifampin MonotherapyCassandra L Brinkman, Suzannah M Schmidt-Malan, Jayawant N Mandrekar, et al.
Diagnostic Microbiology and Infectious Disease|February 25, 2016
In vitro activity of tedizolid against staphylococci isolated from prosthetic joint infectionsSuzannah M Schmidt-Malan, Kerryl E Greenwood Quaintance, Melissa J Karau, et al.
The Journal of Infection|January 11, 2015
Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitisPaschalis Vergidis, Suzannah M Schmidt-Malan, Jayawant N Mandrekar, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2019
Correction for Schmidt-Malan et al., "<i>In Vitro</i> Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam against Resistant Gram-Negative Bacilli"Suzannah M Schmidt-Malan, Avisya J Mishra, Ammara Mushtaq, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
<i>In Vitro</i> Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam against Resistant Gram-Negative BacilliSuzannah M Schmidt-Malan, Avisya J Mishra, Ammara Mushtaq, et al.
Journal of Orthopaedic Surgery and Research|February 14, 2019
Oritavancin polymethylmethacrylate (PMMA)-compressive strength testing and in vitro elutionSuzannah M Schmidt-Malan, Kerryl E Greenwood-Quaintance, Lawrence J Berglund, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Causes and Implications of the Disappearance of Rifampin Resistance in a Rat Model of Methicillin-Resistant Staphylococcus aureus Foreign Body OsteomyelitisCassandra L Brinkman, Harmony L Tyner, Suzannah M Schmidt-Malan, et al.
Diagnostic Microbiology and Infectious Disease|May 2, 2020
In vitro activity of TNP-2092 against periprosthetic joint infection-associated staphylococciCody R Fisher, Suzannah M Schmidt-Malan, Zhenkun Ma, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Diagnostic Microbiology and Infectious Disease|December 3, 2017
Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococciKatharina Neudorfer, Suzannah M Schmidt-Malan, Robin Patel
Journal of Experimental and Applied Animal Sciences|August 13, 2019
A novel rat model of foreign body osteomyelitis for evaluation of antimicrobial efficacyCassandra L Brinkman, Suzannah M Schmidt-Malan, Melissa J Karau, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2016
Rifampin-Based Combination Therapy Is Active in Foreign-Body Osteomyelitis after Prior Rifampin MonotherapyCassandra L Brinkman, Suzannah M Schmidt-Malan, Jayawant N Mandrekar, et al.
Diagnostic Microbiology and Infectious Disease|February 25, 2016
In vitro activity of tedizolid against staphylococci isolated from prosthetic joint infectionsSuzannah M Schmidt-Malan, Kerryl E Greenwood Quaintance, Melissa J Karau, et al.
The Journal of Infection|January 11, 2015
Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitisPaschalis Vergidis, Suzannah M Schmidt-Malan, Jayawant N Mandrekar, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2019
Correction for Schmidt-Malan et al., "<i>In Vitro</i> Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam against Resistant Gram-Negative Bacilli"Suzannah M Schmidt-Malan, Avisya J Mishra, Ammara Mushtaq, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
<i>In Vitro</i> Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam against Resistant Gram-Negative BacilliSuzannah M Schmidt-Malan, Avisya J Mishra, Ammara Mushtaq, et al.
Journal of Orthopaedic Surgery and Research|February 14, 2019
Oritavancin polymethylmethacrylate (PMMA)-compressive strength testing and in vitro elutionSuzannah M Schmidt-Malan, Kerryl E Greenwood-Quaintance, Lawrence J Berglund, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Causes and Implications of the Disappearance of Rifampin Resistance in a Rat Model of Methicillin-Resistant Staphylococcus aureus Foreign Body OsteomyelitisCassandra L Brinkman, Harmony L Tyner, Suzannah M Schmidt-Malan, et al.
Diagnostic Microbiology and Infectious Disease|May 2, 2020
In vitro activity of TNP-2092 against periprosthetic joint infection-associated staphylococciCody R Fisher, Suzannah M Schmidt-Malan, Zhenkun Ma, et al.
Pageof 4